Simtuzumab
Product Specifications
UNSPSC Description
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC)[1].
Target Antigen
Monoamine Oxidase
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/simtuzumab.html
Purity
98.69
Solubility
H2O
Smiles
[Simtuzumab]
References & Citations
[1]Wei Chen, et al. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology. 2020 Aug;72(2):729-741.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99047/Simtuzumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99047/Simtuzumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1318075-13-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1234072-01 0.02 mg (E-Coli)
Recombinant Pseudolarix kaempferi Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details MBS1234072-02 0.02 mg (Yeast)
Recombinant Pseudolarix kaempferi Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details